Literature DB >> 15468312

Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle.

Stefan Girgenrath1, Kening Song, Lisa-Anne Whittemore.   

Abstract

Myostatin (Mstn) is a member of the transforming growth factor-beta family that negatively regulates skeletal muscle mass. Mstn knockout mice have greater skeletal muscle mass than wild-type littermates. We investigated the effect of Mstn on fiber type by comparing adult muscles from the murine Mstn knockout with wild-type controls. Based on myofibrillar ATPase staining, the soleus of Mstn knockout mice displays a larger proportion of fast type II fibers and a reduced proportion of slow type I fibers compared with wild-type animals. Based on staining for succinate dehydrogenase (SDH) activity, a larger proportion of glycolytic fibers and a reduced proportion of oxidative fibers occur in the extensor digitorum longus (EDL) of Mstn knockouts. These differences in distribution of fiber types are accompanied by differences in the expression of myosin heavy chain (MHC) isoforms. In both Mstn knockout soleus and EDL, larger numbers of faster MHC isoforms are expressed at the expense of slower isoforms when compared with wild-type littermates. Thus, the absence of Mstn in the knockout mouse leads to an overall faster and more glycolytic muscle phenotype. This muscle phenotype is likely a consequence of developmental processes, and inhibition of Mstn in adults does not cause a transformation to a more fast and glycolytic phenotype. Our findings suggest that myostatin has a critical role in regulating the formation, proliferation, or differentiation of fetal myoblasts and postnatal fibers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15468312     DOI: 10.1002/mus.20175

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  89 in total

1.  Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type.

Authors:  Samuel M Cadena; Kathleen N Tomkinson; Travis E Monnell; Matthew S Spaits; Ravindra Kumar; Kathryn W Underwood; R Scott Pearsall; Jennifer L Lachey
Journal:  J Appl Physiol (1985)       Date:  2010-05-13

Review 2.  Metabolic benefits of resistance training and fast glycolytic skeletal muscle.

Authors:  Nathan K LeBrasseur; Kenneth Walsh; Zoltan Arany
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-11-02       Impact factor: 4.310

3.  METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.

Authors:  Alexandra C McPherron
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2010-12

4.  Fine-mapping of genes determining extrafusal fiber properties in murine soleus muscle.

Authors:  A M Carroll; R Cheng; E S R Collie-Duguid; C Meharg; M E Scholz; S Fiering; J L Fields; A A Palmer; A Lionikas
Journal:  Physiol Genomics       Date:  2017-01-13       Impact factor: 3.107

5.  Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis.

Authors:  Timothy M Miller; Soo H Kim; Koji Yamanaka; Mark Hester; Priya Umapathi; Hannah Arnson; Liza Rizo; Jerry R Mendell; Fred H Gage; Don W Cleveland; Brian K Kaspar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-12       Impact factor: 11.205

6.  Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease.

Authors:  Liping Zhang; Vik Rajan; Eugene Lin; Zhaoyong Hu; H Q Han; Xiaolan Zhou; Yanping Song; Hosung Min; Xiaonan Wang; Jie Du; William E Mitch
Journal:  FASEB J       Date:  2011-01-31       Impact factor: 5.191

7.  Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice.

Authors:  Michael W Lawlor; Benjamin P Read; Rachel Edelstein; Nicole Yang; Christopher R Pierson; Matthew J Stein; Ariana Wermer-Colan; Anna Buj-Bello; Jennifer L Lachey; Jasbir S Seehra; Alan H Beggs
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

8.  Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.

Authors:  Ferrill F Rose; Virginia B Mattis; Hansjörg Rindt; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

Review 9.  Mechanisms for fiber-type specificity of skeletal muscle atrophy.

Authors:  Yichen Wang; Jeffrey E Pessin
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-05       Impact factor: 4.294

10.  Reduced myofibrillar connectivity and increased Z-disk width in nebulin-deficient skeletal muscle.

Authors:  Paola Tonino; Christopher T Pappas; Bryan D Hudson; Siegfried Labeit; Carol C Gregorio; Henk Granzier
Journal:  J Cell Sci       Date:  2010-01-05       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.